About the Journal
About the Journal
The Journal of Pharmacovigilance and Drug Research (JPADR) is the official peer-reviewed journal of the Global Pharmacovigilance Society. JPADR is an international, open-access scholarly journal dedicated to publishing high-quality research that advances the science and practice of pharmacovigilance, drug safety, and medication risk management.
The journal provides an international platform for researchers, clinicians, academicians, healthcare professionals, regulators, and pharmaceutical scientists to disseminate original research, reviews, case reports, and scientific communications that contribute to improving patient safety and the safe use of medicines worldwide.
Aims and Scope
JPADR publishes original research, review articles, case reports, short communications, editorials, and letters covering all aspects of pharmacovigilance and drug safety.
The journal welcomes manuscripts in, but not limited to, the following areas:
- Pharmacovigilance
- Drug Safety
- Adverse Drug Reactions (ADR)
- Medication Safety
- Pharmacoepidemiology
- Drug Risk Management
- Regulatory Science
- Signal Detection and Signal Management
- Clinical Research and Clinical Trials
- Drug Effectiveness and Efficacy
- Post-Marketing Surveillance
- Risk Evaluation and Mitigation Strategies (REMS)
- Medication Error Prevention
- Drug Utilization Research
- Patient Safety
Target Audience
JPADR serves researchers, professors, clinicians, healthcare professionals, pharmacists, regulatory authorities, pharmaceutical industry professionals, students, and policymakers involved in pharmacovigilance, drug safety, and clinical research worldwide.
Journal Objectives
The primary objective of JPADR is to establish a globally recognized scientific platform for communicating innovative research findings, evidence-based practices, and advancements in pharmacovigilance and drug safety to improve patient care and public health.
Publication Ethics
JPADR follows internationally accepted publication ethics and best editorial practices. Authors are strongly encouraged to review the journal's Publication Ethics and Malpractice Statement before submitting their manuscripts.
For detailed ethical guidelines, please refer to the Publication Ethics page available on the journal website.
Article Processing Charges (APC)
Publication in JPADR is subject to an Article Processing Charge (APC). Details regarding publication fees, waivers, and payment policies are available on the Article Processing Charges page.
Publication Frequency
JPADR is published Quarterly, with four issues released each calendar year:
- January – March
- April – June
- July – September
- October – December
Open Access Policy
JPADR is a fully Open Access journal. All published articles are immediately and permanently available online without subscription or access charges.
Readers are free to read, download, copy, distribute, print, search, link to, or use the full text of published articles for any lawful purpose without prior permission from the publisher or the authors, subject to the applicable Creative Commons license.
No fees are charged for accessing, reading, or downloading published articles.
Digital Archiving and Preservation
To ensure long-term preservation and accessibility of scholarly content, JPADR participates in internationally recognized digital preservation programs, including:
- CLOCKSS (Controlled Lots of Copies Keep Stuff Safe)
- LOCKSS (Lots of Copies Keep Stuff Safe)
Copyright and Licensing
Beginning with publications from 2026 onwards, all articles are published under the Creative Commons Attribution (CC BY 4.0) License.
Authors retain full copyright of their published work while granting the journal the right to publish and disseminate the article. The CC BY license permits sharing, adaptation, distribution, and reproduction in any medium, provided appropriate credit is given to the original author(s) and source.
About the Global Pharmacovigilance Society
The Global Pharmacovigilance Society is an international professional organization comprising pharmacovigilance experts, clinicians, academicians, researchers, regulatory professionals, and healthcare leaders dedicated to improving patient safety through effective pharmacovigilance practices.
The Society promotes excellence in drug safety by encouraging scientific research, educational activities, international collaborations, conferences, webinars, training programs, and public awareness initiatives on adverse drug reaction (ADR) reporting and medication safety.
Its mission is to strengthen global pharmacovigilance systems and contribute to safer healthcare through education, innovation, collaboration, and scientific research.
